Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
about
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases.Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.Is 2-Hydroxypropyl-β-cyclodextrin a Suitable Carrier for Central Administration of Δ9 -Tetrahydrocannabinol? Preclinical Evidence.Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology.Cannabis Therapeutics and the Future of Neurology
P2860
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cannabinoids therapeutic use: ...... D oromucosal spray and others?
@en
type
label
Cannabinoids therapeutic use: ...... D oromucosal spray and others?
@en
prefLabel
Cannabinoids therapeutic use: ...... D oromucosal spray and others?
@en
P2093
P2860
P1476
Cannabinoids therapeutic use: ...... D oromucosal spray and others?
@en
P2093
Mauro Maccarrone
Miguel Casas
Rafael Maldonado
Thomas Henze
P2860
P304
P356
10.1080/17512433.2017.1292849
P407
P577
2017-02-28T00:00:00Z